 |
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin |
Avery-Kiejda, Kelly A.; Zhang, Xu Dong; Adams, Luke J.; Scott, Rodney J.; Vojtesek, Borivoj... More
|
2008 |
—
|
|
 |
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the oblimersen melanoma study group |
Bedikian, Agop Y.; Millward, Michael; Kirkwood, John M.; Haluska, Frank G.; Pehamberger, Hubert... More
|
2006 |
—
|
|
 |
Nucleotide excision repair gene expression after cisplatin treatment in melanoma |
Bowden, Nikola A.; Ashton, Katie A.; Kiejda, Kelly A.; Zhang, Xu Dong; Hersey, Peter... More
|
2010 |
—
|
|
 |
Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein |
Chen, Li Hua; Jiang, Chen Chen; Watts, Ralph; Thorne, Rick F.; Kiejda, Kelly A.... More
|
2008 |
—
|
|
 |
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma |
Eisen, Tim; Trefzer, Uwe; Hamilton, Anne; Hersey, Peter; Millward, Michael... More
|
2010 |
—
|
|
 |
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with Carboplatin and Paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma |
Hauschild, Axel; Agarwala, Sanjiv S; Peschel, Christian; Schadendorf, Dirk; Garbe, Claus... More
|
2009 |
—
|
|
 |
Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma |
Hersey, Peter; Zhang, Xu Dong |
2008 |
|
|
 |
Overcoming resistance to apoptosis in cancer therapy |
Hersey, Peter; Zhang, Xu Dong; Mhaidat, Nizar |
2008 |
—
|
|
 |
Current strategies in overcoming resistance of cancer cells to apaptosis melanoma as a model |
Hersey, Peter; Zhuang, L.; Zhang, X. D. |
2006 |
—
|
|
 |
Current strategies in overcoming resistance of cancer cells to apaptosis melanoma as a model |
Hersey, Peter; Zhuang, L.; Zhang, X. D. |
2006 |
—
|
|
 |
Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma |
Hersey, Peter; Nguyen, T.; Farrelly, M.; Menzies, S.W.; Hirst, D.... More
|
2005 |
|
|
 |
Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma |
Hersey, Peter |
2006 |
|
|
 |
Treatment combinations targeting apoptosis to improve immunotherapy of melanoma |
Hersey, Peter; Zhang, Xu Dong |
2009 |
|
|
 |
Metabolic approaches to treatment of melanoma |
Hersey, Peter; Watts, Ralph Neal; Zhang, Xu Dong; Hackett, John |
2009 |
|
|
 |
Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress |
Jiang, Chen Chen; Lucas, Keryn; Avery-Kiejda, Kelly A.; Wade, Margaret; deBock, Charles E.... More
|
2008 |
—
|
|
List View
